Idofnib 100 mg Capsule
$11.29
$10.20
Idofnib 100 mg capsules are a targeted therapy classified as tyrosine kinase inhibitors, specifically designed to address idiopathic pulmonary fibrosis (IPF), a progressive lung condition characterized by scarring of lung tissue. By inhibiting specific pathways involved in fibrosis, Idofnib effectively helps to slow the deterioration of lung function and mitigates the harmful changes in lung architecture associated with this disease. Patients using Idofnib should be aware of potential side effects, including liver enzyme elevations and gastrointestinal disturbances, necessitating regular monitoring during treatment. As with any medication, it is crucial to discuss your complete medical history with your healthcare provider to ensure safety and efficacy. The administration of Idofnib is typically once daily, and it is vital to adhere to your prescribed dosage for optimal results. Additionally, patients should avoid pregnancy while on this medication due to possible risks to the fetus. Idofnib represents a significant advancement in the management of IPF, offering hope to those affected by this challenging condition. Always consult with your healthcare professional for tailored advice and information regarding your treatment plan.
Quantity
Active Pharmaceutical Ingredient
Uses
• Idofnib 100 mg capsule is primarily used in the treatment of specific types of cancer. This medication works by targeting and inhibiting certain pathways that are essential for cancer cell growth and survival. As a result, it helps to slow down the progression of the disease. Patients often receive Idofnib 100 mg capsule as part of a comprehensive treatment plan.
• In clinical practice, Idofnib 100 mg capsule is utilized for patients who have shown resistance to other therapies. It is particularly beneficial for those whose cancer has not responded well to standard treatment options. The unique mechanism of action of Idofnib allows it to provide an alternative for managing challenging cases. Physicians monitor the effectiveness of this medication closely during treatment.
• Idofnib 100 mg capsule may be prescribed in combination with other medications to enhance therapeutic outcomes. This combination approach can lead to improved efficacy in combating cancer. Doctors often tailor the treatment regimen based on individual patient needs and responses. The use of Idofnib 100 mg capsule in combination therapies is becoming increasingly common in oncology.
• For patients participating in clinical trials, Idofnib 100 mg capsule may be investigated for its potential benefits in various treatment settings. These studies aim to gather more data on its effectiveness and safety profile. As research evolves, Idofnib 100 mg capsule could play a significant role in expanding treatment options for specific cancer types. Participation in such trials can provide patients with access to cutting-edge therapies.
Benefits
Idiopathic pulmonary fibrosis: Idiopathic pulmonary fibrosis is a lung disease in which lung tissue becomes thick and stiff, eventually forming scar tissue in the lungs. The scarring, or fibrosis, appears to result from a cycle of damage and healing that occurs in the lungs. These changes are irreversible, and the first symptoms may be shortness of breath or a dry cough. Idofnib 100 Capsule kills or stops the growth of cancer cells and also prevents cancer cells from multiplying. It is possible that you may experience some unpleasant side effects. Discuss this together along with your physician when you have any concerns. Interstitial lung disease: Interstitial lung disease (ILD) refers to a group of lung diseases that affect the interstitium, which is the tissue and space around the air sacs in the lungs. These conditions cause inflammation and scarring of the lung tissue, leading to difficulty in breathing. Idofnib Capsule kills or stops the growth of cancer cells and also prevents cancer cells from multiplying. You may additionally experience some unpleasant side effects. If you've got any concerns, please speak them together along with your doctor. Non-small cell lung cancer (NSCLC) Non-small cell lung cancer is one of the main types of lung cancer and affects both smokers and non-smokers. Idofnib 100 mg helps treat NSCLC and can be given alone or in combination with other medicines. It is a strong and very toxic medicine, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol during this treatment and drink plenty of water to stay hydrated. Systemic sclerosis: Systemic sclerosis, commonly known as scleroderma, is an autoimmune disease that can affect various parts of the body, including the skin and internal organs. By reducing the progression of fibrosis, Idofnib 100 Capsule may help to maintain or preserve lung function, leading to better lung capacity and potentially slowing the decline in lung function.
Side Effects
Like all medicines, Idofnib 100 mg Capsule may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Diarrhoea
• Stomach upset
• Loss of appetite
• Weight loss
• Fatigue
• Headache
• Unhealed wound
Common Side Effects
• Altered blood pressure
• Liver problems (jaundice)
• Dark brown urine
• Yellowing of the skin
• Lack of energy
• Shortness of breath
• Numbness or weakness
• Difficulty in speech
• Malena ( blood in stool)
How To Use
Idofnib 100 mg Capsule is available in the form of oral capsules to be taken by mouth as prescribed by your doctor. The frequency and dosage of the medicine will be decided by your doctor depending on the severity of the disease and certain other factors and how your body responds to the treatment.
Safety Advice
• Alcohol: Drinking alcohol while taking Idofnib 100 mg is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: In patients with kidney disease, Idofnib Capsule should be used with caution, and kidney function should be closely monitored. If you experience any side effects or you have concerns about using this Idofnib 100 Capsule, please consult your doctor.
• Breastfeeding: There are no data on the presence of Idofnib 100 Capsule or its metabolites in human milk or effects on nursing infants or lactation. Because of the potential for serious adverse reactions in nursing infants, women should be advised not to breastfeed during treatment with Idofnib 100 mg Capsule and for 2 weeks after the last dose.
• Liver: In patients with liver disease, Idofnib 100 mg Capsule should be used with caution and liver function should be closely monitored. If you experience any side effects or you have concerns about using this Idofnib 100 Capsule, please consult your doctor.
• Pregnancy: The use of Idofnib 100 mg Capsule is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
• Driving: Idofnib 100 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Idofnib Capsule.